Cargando…

Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis

Treatment with alternating electric fields at an intermediate frequency (100–300 kHz), referred to as tumor treating fields (TTF) therapy, inhibits cancer cell proliferation. In the present study, we demonstrated that TTF application suppressed the metastatic potential of U87 and U373 glioblastoma c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Eun Ho, Song, Hyo Sook, Yoo, Seung Hoon, Yoon, Myonggeun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323142/ https://www.ncbi.nlm.nih.gov/pubmed/27556184 http://dx.doi.org/10.18632/oncotarget.11372

Ejemplares similares

Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy
por: Jo, Yunhui, et al.
Publicado: (2018)

Biological effect of an alternating electric field on cell proliferation and synergistic antimitotic effect in combination with ionizing radiation
por: Kim, Eun Ho, et al.
Publicado: (2016)

Effectiveness of a Fractionated Therapy Scheme in Tumor Treating Fields Therapy
por: Jo, Yunhui, et al.
Publicado: (2019)

Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase
por: Luengo-Gil, Ginés, et al.
Publicado: (2016)

Selective toxicity of tumor treating fields to melanoma: an in vitro and in vivo study
por: Jo, Yunhui, et al.
Publicado: (2018)

Gold nanoparticles as a potent radiosensitizer in neutron therapy
por: Kim, Eun Ho, et al.
Publicado: (2017)

Effect of duty cycles of tumor-treating fields on glioblastoma cells and normal brain organoids
por: Ye, Eunbi, et al.
Publicado: (2021)

Effect of duty cycles of tumor-treating fields on glioblastoma cells and normal brain organoids
por: Ye, Eunbi, et al.
Publicado: (2022)

The Value of Tumor Treating Fields in Glioblastoma
por: Zhang, Chaochao, et al.
Publicado: (2020)

Indirubin inhibits cell proliferation, migration, invasion and angiogenesis in tumor-derived endothelial cells
por: Li, Zhuohong, et al.
Publicado: (2018)

The Candidate Tumor Suppressor Gene SLC8A2 Inhibits Invasion, Angiogenesis and Growth of Glioblastoma
por: Qu, Mingqi, et al.
Publicado: (2017)

Current usage of tumor treating fields for glioblastoma
por: Lassman, Andrew B, et al.
Publicado: (2020)

Omeprazole Inhibits Glioblastoma Cell Invasion and Tumor Growth
por: Jin, Un-Ho, et al.
Publicado: (2020)

Blockade of ONECUT2 expression in ovarian cancer inhibited tumor cell proliferation, migration, invasion and angiogenesis
por: Lu, Tongyi, et al.
Publicado: (2018)

Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition
por: Kessler, Almuth F., et al.
Publicado: (2018)

Impaired angiogenesis in the enalapril-treated neonatal rat kidney
por: Yim, Hyung Eun, et al.
Publicado: (2016)

Nobiletin Inhibits CD36-Dependent Tumor Angiogenesis, Migration, Invasion, and Sphere Formation Through the Cd36/Stat3/Nf-Κb Signaling Axis
por: Sp, Nipin, et al.
Publicado: (2018)

Tumor-Treating Fields in Glioblastomas: Past, Present, and Future
por: Guo, Xiaopeng, et al.
Publicado: (2022)

Tumor-Treating Fields Inhibit the Metastatic Potential of Osteosarcoma Cells
por: Oh, Ju Yeon, et al.
Publicado: (2020)

SCO-spondin oligopeptide inhibits angiogenesis in glioblastoma
por: Bibes, Romain, et al.
Publicado: (2017)

Effectiveness of tumor‑treating fields to reduce the proliferation and migration of liposarcoma cell lines
por: Lee, Won Seok, et al.
Publicado: (2023)

Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma
por: Ahir, Bhavesh K., et al.
Publicado: (2020)

Angiogenesis and radiological tumor growth in patients with glioblastoma
por: Mikkelsen, Vilde Elisabeth, et al.
Publicado: (2018)

Inhibition of FABP6 Reduces Tumor Cell Invasion and Angiogenesis through the Decrease in MMP-2 and VEGF in Human Glioblastoma Cells
por: Pai, Feng-Cheng, et al.
Publicado: (2021)

Effects of Anti-Angiogenesis on Glioblastoma Growth and Migration: Model to Clinical Predictions
por: Scribner, Elizabeth, et al.
Publicado: (2014)

Tumor treating fields increases membrane permeability in glioblastoma cells
por: Chang, Edwin, et al.
Publicado: (2018)

Analysis of physical characteristics of Tumor Treating Fields for human glioblastoma
por: Lok, Edwin, et al.
Publicado: (2017)

Tumor treating fields in the management of Glioblastoma: opportunities for advanced imaging
por: Soni, Vikram S., et al.
Publicado: (2019)

Enhancing glioblastoma treatment through the integration of tumor-treating fields
por: Szklener, Katarzyna, et al.
Publicado: (2023)

Hispolon Induces Apoptosis, Suppresses Migration and Invasion of Glioblastoma Cells and Inhibits GBM Xenograft Tumor Growth In Vivo
por: Liao, Kuan-Fu, et al.
Publicado: (2021)

JSI-124 Suppresses Invasion and Angiogenesis of Glioblastoma Cells In Vitro
por: Yuan, Guang, et al.
Publicado: (2015)

Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion
por: Chen, Wen-Liang, et al.
Publicado: (2015)

Celastrus orbiculatus extract inhibits the migration and invasion of human glioblastoma cells in vitro
por: Gu, Hao, et al.
Publicado: (2016)

Isolinderalactone inhibits glioblastoma cell supernatant-induced angiogenesis
por: Lee, Seo-Yeon, et al.
Publicado: (2022)

Juglone reduces growth and migration of U251 glioblastoma cells and disrupts angiogenesis
por: Wang, Jian, et al.
Publicado: (2017)

Circadian regulator CLOCK promotes tumor angiogenesis in glioblastoma
por: Pang, Lizhi, et al.
Publicado: (2023)

Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields
por: Pandey, Manjari, et al.
Publicado: (2022)

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
por: Omar, Ayman I.
Publicado: (2014)

The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists
por: Burri, Stuart H., et al.
Publicado: (2018)

Tumor Treating Fields for Glioblastoma Therapy During the COVID-19 Pandemic
por: Gatson, Na Tosha N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vhsfjo57nr1aq6vd7bt5v91jbu